Rolf H. Günther
Profile
Dr. Rolf H.
Günther, MD PhD, is Chief Executive Officer at Bicycle Therapeutics Ltd.
Dr. Günther was previously employed as VP-Global Clinical Research & Development by Aventis Behring LLC and Chief Executive & Operating Officer by Affimed Therapeutics AG.
He received his doctorate degree from The Johannes Gutenberg University of Mainz.
Former positions of Rolf H. Günther
| Companies | Position | End |
|---|---|---|
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Chief Executive Officer | - |
| Aventis Behring LLC | Corporate Officer/Principal | - |
| BICYCLE THERAPEUTICS PLC | Chief Executive Officer | - |
Training of Rolf H. Günther
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| BICYCLE THERAPEUTICS PLC | Health Technology |
| Private companies | 2 |
|---|---|
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
| Aventis Behring LLC |
- Stock Market
- Insiders
- Rolf H. Günther
